VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors GBX 16.06 +0.16 (+1.03%) (As of 09/16/2024 09:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors CYBG vs. CCFS, CIHL, IL0A, OCI, JEO, AGT.LN, AFX, JESC, SLPE, and BGSCShould you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), Oakley Capital Investments (OCI), European Opportunities Trust (JEO), AVI Global Trust (AGT.LN), Alpha FX Group (AFX), JPMorgan European Smaller Companies Trust (JESC), Standard Life Private Equity Trust (SLPE), and BMO Global Smaller Companies (BGSC). VanEck Bionic Engineering UCITS ETF A Acc vs. Charter Court Financial Services Grp Caribbean Investment Permanent TSB Group Oakley Capital Investments European Opportunities Trust AVI Global Trust Alpha FX Group JPMorgan European Smaller Companies Trust Standard Life Private Equity Trust BMO Global Smaller Companies VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking. Do analysts rate CYBG or CCFS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VanEck Bionic Engineering UCITS ETF A Acc 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACharter Court Financial Services Grp 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media prefer CYBG or CCFS? In the previous week, VanEck Bionic Engineering UCITS ETF A Acc and VanEck Bionic Engineering UCITS ETF A Acc both had 1 articles in the media. Charter Court Financial Services Grp's average media sentiment score of 0.64 beat VanEck Bionic Engineering UCITS ETF A Acc's score of 0.59 indicating that Charter Court Financial Services Grp is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VanEck Bionic Engineering UCITS ETF A Acc 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charter Court Financial Services Grp 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVanEck Bionic Engineering UCITS ETF A Acc£1.24B0.19N/A-£7.10-2.26Charter Court Financial Services Grp£221.10M3.23N/A£46.306.37 Does the MarketBeat Community favor CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc received 104 more outperform votes than Charter Court Financial Services Grp when rated by MarketBeat users. However, 73.88% of users gave Charter Court Financial Services Grp an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote. CompanyUnderperformOutperformVanEck Bionic Engineering UCITS ETF A AccOutperform Votes20350.88% Underperform Votes19649.12% Charter Court Financial Services GrpOutperform Votes9973.88% Underperform Votes3526.12% Is CYBG or CCFS a better dividend stock? VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share and has a dividend yield of 0.0%. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio. Is CYBG or CCFS more profitable? Company Net Margins Return on Equity Return on Assets VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A Charter Court Financial Services Grp N/A N/A N/A SummaryCharter Court Financial Services Grp beats VanEck Bionic Engineering UCITS ETF A Acc on 5 of the 9 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Coin Could 10x FASTER Than BitcoinThe Bitcoin Halving ignited the 2024 boom, and altcoins are primed to SKYROCKET. Last year we tipped off our community with altcoins that delivered EXPLOSIVE gains. Now, we've uncovered an even bigger potential winner for the 2024 Bitcoin Halving bull run.Click here to take advantage of this time-sensitive offer. Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYBG vs. The Competition Export to ExcelMetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON ExchangeMarket Cap£230.42M£248.07M£9.67B£1.41BDividend Yield2.25%15.57%10.55%11.72%P/E Ratio-2.262.1447.931,587.95Price / Sales0.19116.343,309.61181,610.10Price / Cash0.130.2428.7732.91Price / Book0.050.442.932.83Net IncomeN/A£213M£1.02B£152.60M7 Day Performance0.21%0.03%1.60%7.41%1 Month Performance-0.29%-0.05%4.43%-1.05%1 Year PerformanceN/A0.73%18.43%27.07% VanEck Bionic Engineering UCITS ETF A Acc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCFSCharter Court Financial Services Grp0 of 5 stars0.00 / 5 starsGBX 295+3.7%N/AN/A£713.62M£221.10M6.37676Gap UpCIHLCaribbean Investment0 of 5 stars0.00 / 5 starsGBX 26.50flatN/A+0.0%£35.27M£29.20M3.08N/AGap UpHigh Trading VolumeIL0APermanent TSB Group0 of 5 stars0.00 / 5 starsGBX 2.38flatN/AN/A£12.99M£406M5.532,236OCIOakley Capital Investments0 of 5 stars0.00 / 5 starsGBX 504flatN/A+9.6%£889.16M£54.72M1,866.67N/ADividend AnnouncementHigh Trading VolumeJEOEuropean Opportunities Trust0 of 5 stars0.00 / 5 starsGBX 843-2.4%N/A+0.0%£886.70M£-62,326,000.00-12.93N/AAGT.LNAVI Global Trust0 of 5 stars0.00 / 5 starsN/AN/AN/A£812.93M£51.62M20.82N/AHigh Trading VolumeAFXAlpha FX Group0 of 5 stars0.00 / 5 starsGBX 1,920-0.5%N/A+0.0%£810.18M£89.43M3,200.00214JESCJPMorgan European Smaller Companies Trust0 of 5 stars0.00 / 5 starsGBX 499-1.0%N/AN/A£795.72M£114.05M7.60N/APositive NewsSLPEStandard Life Private Equity Trust0 of 5 stars0.00 / 5 starsGBX 512-1.5%N/A+21.4%£787.18M£251.60M3.30N/APositive NewsBGSCBMO Global Smaller Companies0 of 5 stars0.00 / 5 starsGBX 140.60-0.8%N/A+0.0%£769.56M£303.85M2.77N/A Related Companies and Tools Related Companies: Charter Court Financial Services Grp Competitors Caribbean Investment Competitors Permanent TSB Group Competitors Oakley Capital Investments Competitors European Opportunities Trust Competitors AVI Global Trust Competitors Alpha FX Group Competitors JPMorgan European Smaller Companies Trust Competitors Standard Life Private Equity Trust Competitors BMO Global Smaller Companies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CYBG) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredFortune: Nexus Technology has “ignited a gold rush”Business Insider estimates it could grow 8,966% in the near future... And Goldman Sachs says it could grow ...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.